85 related articles for article (PubMed ID: 12874489)
21. An Evaluation on the Efficacy and Safety of Treatments for Attention Deficit Hyperactivity Disorder in Children and Adolescents: a Comparison of Multiple Treatments.
Li Y; Gao J; He S; Zhang Y; Wang Q
Mol Neurobiol; 2017 Nov; 54(9):6655-6669. PubMed ID: 27738872
[TBL] [Abstract][Full Text] [Related]
22. Combined Stimulant and Guanfacine Administration in Attention-Deficit/Hyperactivity Disorder: A Controlled, Comparative Study.
McCracken JT; McGough JJ; Loo SK; Levitt J; Del'Homme M; Cowen J; Sturm A; Whelan F; Hellemann G; Sugar C; Bilder RM
J Am Acad Child Adolesc Psychiatry; 2016 Aug; 55(8):657-666.e1. PubMed ID: 27453079
[TBL] [Abstract][Full Text] [Related]
23. Clonidine for sedation in the critically ill: a systematic review and meta-analysis (protocol).
Jing Wang G; Belley-Coté E; Burry L; Duffett M; Karachi T; Perri D; Alhazzani W; D'Aragon F; Wunsch H; Rochwerg B
Syst Rev; 2015 Nov; 4():154. PubMed ID: 26542363
[TBL] [Abstract][Full Text] [Related]
24. Changing patterns of alpha agonist medication use in children and adolescents 2009-2011.
Fiks AG; Mayne SL; Song L; Steffes J; Liu W; McCarn B; Margolis B; Grimes A; Gotlieb E; Localio R; Ross ME; Grundmeier RW; Wasserman R; Leslie LK
J Child Adolesc Psychopharmacol; 2015 May; 25(4):362-7. PubMed ID: 25919708
[TBL] [Abstract][Full Text] [Related]
25. The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysis. Part 1: psychostimulants, alpha-2 agonists, and atomoxetine.
Pringsheim T; Hirsch L; Gardner D; Gorman DA
Can J Psychiatry; 2015 Feb; 60(2):42-51. PubMed ID: 25886655
[TBL] [Abstract][Full Text] [Related]
26. Predictors of polypharmacy and off-label prescribing of psychotropic medications: a national survey of child and adolescent psychiatrists.
Kearns MA; Hawley KM
J Psychiatr Pract; 2014 Nov; 20(6):438-47. PubMed ID: 25406048
[TBL] [Abstract][Full Text] [Related]
27. Risperidone added to parent training and stimulant medication: effects on attention-deficit/hyperactivity disorder, oppositional defiant disorder, conduct disorder, and peer aggression.
Gadow KD; Arnold LE; Molina BS; Findling RL; Bukstein OG; Brown NV; McNamara NK; Rundberg-Rivera EV; Li X; Kipp HL; Schneider J; Farmer CA; Baker JL; Sprafkin J; Rice RR; Bangalore SS; Butter EM; Buchan-Page KA; Hurt EA; Austin AB; Grondhuis SN; Aman MG
J Am Acad Child Adolesc Psychiatry; 2014 Sep; 53(9):948-959.e1. PubMed ID: 25151418
[TBL] [Abstract][Full Text] [Related]
28. Safety and efficacy of clonidine and clonidine extended-release in the treatment of children and adolescents with attention deficit and hyperactivity disorders.
Ming X; Mulvey M; Mohanty S; Patel V
Adolesc Health Med Ther; 2011; 2():105-12. PubMed ID: 24600280
[TBL] [Abstract][Full Text] [Related]
29. Evidence based administration of risperidone and paliperidone for the treating conduct disorder.
Ghanizadeh A
J Res Med Sci; 2013 Nov; 18(11):998-1003. PubMed ID: 24523788
[TBL] [Abstract][Full Text] [Related]
30. Focus on Guanfacine Extended-release: A Review of its Use in Child and Adolescent Psychiatry.
Elbe D; Reddy D
J Can Acad Child Adolesc Psychiatry; 2014 Feb; 23(1):48-60. PubMed ID: 24516477
[TBL] [Abstract][Full Text] [Related]
31. Combination pharmacotherapy for psychiatric disorders in children and adolescents: prevalence, efficacy, risks and research needs.
Jureidini J; Tonkin A; Jureidini E
Paediatr Drugs; 2013 Oct; 15(5):377-91. PubMed ID: 23757196
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: clinical strategies.
Shier AC; Reichenbacher T; Ghuman HS; Ghuman JK
J Cent Nerv Syst Dis; 2013; 5():1-17. PubMed ID: 23650474
[TBL] [Abstract][Full Text] [Related]
33. Pharmacology and pharmacogenetics of pediatric ADHD with associated aggression: a review.
Patel BD; Barzman DH
Psychiatr Q; 2013 Dec; 84(4):407-15. PubMed ID: 23443759
[TBL] [Abstract][Full Text] [Related]
34. Clonidine extended-release in attention-deficit hyperactivity disorder: profile report.
Croxtall JD
CNS Drugs; 2012 Mar; 26(3):277-9. PubMed ID: 22248146
[No Abstract] [Full Text] [Related]
35. The treatment of severe child aggression (TOSCA) study: Design challenges.
Farmer CA; Arnold LE; Bukstein OG; Findling RL; Gadow KD; Li X; Butter EM; Aman MG
Child Adolesc Psychiatry Ment Health; 2011 Nov; 5(1):36. PubMed ID: 22074813
[TBL] [Abstract][Full Text] [Related]
36. An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults.
Wilens TE; Morrison NR; Prince J
Expert Rev Neurother; 2011 Oct; 11(10):1443-65. PubMed ID: 21955201
[TBL] [Abstract][Full Text] [Related]
37. Clonidine extended-release: in attention-deficit hyperactivity disorder.
Croxtall JD
Paediatr Drugs; 2011 Oct; 13(5):329-36. PubMed ID: 21888447
[TBL] [Abstract][Full Text] [Related]
38. ADHD in children and adolescents.
Keen D; Hadijikoumi I
BMJ Clin Evid; 2011 Feb; 2011():. PubMed ID: 21718557
[TBL] [Abstract][Full Text] [Related]
39. Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD.
Kollins SH; Jain R; Brams M; Segal S; Findling RL; Wigal SB; Khayrallah M
Pediatrics; 2011 Jun; 127(6):e1406-13. PubMed ID: 21555501
[TBL] [Abstract][Full Text] [Related]
40. Are clinicians' assessments of improvements in children's functioning "global"?
De Los Reyes A; Alfano CA; Beidel DC
J Clin Child Adolesc Psychol; 2011; 40(2):281-94. PubMed ID: 21391024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
